Email not displaying correctly? View it in your browser ([link removed]).
[link removed]
Issue 1,566: May 12, 2021
Top Stories
* FDA expands EUA for Pfizer-BioNTech COVID-19 Vaccine for ages 12–15 years; ACIP convenes today, May 12, to discuss
* ACIP discussed rabies vaccine and dengue vaccine on May 5; IAC summarizes meeting
* CDC updates "FAQs for Private and Public Healthcare Providers about Implementing the CDC COVID-19 Vaccination Program in Provider Practices"
* Association of Immunization Managers releases “COVID-19 Vaccine Communication Resources”
* Vaccines.gov helps individuals find nearby COVID-19 vaccination sites using web and text options; available in English and Spanish
* MMWR Recap: CDC publishes COVID-19 vaccine updates on safety monitoring, anxiety-related adverse events, and effectiveness studies on May 7; previously issued as MMWR Early Releases
* Sabin-Aspen Vaccine Science and Policy Group releases its newest meeting report, “Powering Vaccine R&D: Opportunities for Transformation”
* CDC publishes “Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021” in MMWR, describing use of botulinum antitoxin
* CDC’s Dr. Anne Schuchat named 2021 Service to America Medal Finalist; you can vote daily for your favorite finalist
* Celebrate vaccination progress with patients and staff! Order IAC’s “I Got My COVID-19 Vaccine” buttons—stickers available, too.
* Ready to ship! Order IAC’s laminated version of CDC’s 2021 immunization schedule today!
* IAC Spotlight! Our IAC Image Library leads you to hundreds of disease photos to educate staff and patients about the importance of vaccination
* IAC experts called on by news media
* Not-to-miss immunization articles in the news
World News
* CDC and WHO report on progress toward worldwide polio eradication in MMWR and Weekly Epidemiological Record, respectively
Featured Resources
* In IAC’s “Video of the Week,” CDC uses American Sign Language to share what to expect when someone gets vaccinated against COVID-19
* CHOP’s VEC expands its My COVID-19 Vaccine Experience video series to include racially and ethnically diverse colleagues, and young adults
* Now available in Spanish! IAC’s “I Got My COVID-19 Vaccine” Facebook profile photo frame
* Use IAC's expanded "Repository of Resources for Maintaining Immunization during the COVID-19 Pandemic" for catch-up initiatives
Education and Training
* National Academy of Medicine will offer "International Workshop on COVID-19 Lessons to Inform Pandemic Influenza Response" on May 18, 21, and 25
Immunization PSAs from the Archive
* In this jaunty PSA from 2001 by the Phoenix Fire Department, Diamondback left fielder Luis Gonzalez hits a home run promoting childhood vaccinations, sharing why he and his wife vaccinated their triplets
------------------------------------------------------------
Top Stories
------------------------------------------------------------
FDA expands EUA for Pfizer-BioNTech COVID-19 Vaccine for ages 12–15 years; ACIP convenes today, May 12, to discuss
On May 10, the Food and Drug Administration (FDA) ([link removed]) expanded the age groups covered by the Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to adolescents ages 12–15 years. Until now, this EUA covered people age 16 years and older. The regulatory action was based on safety data, disease-reduction data, and immunogenicity data.
The following updated resources were included with the FDA news release:
* Pfizer-BioNTech COVID-19 Vaccine EUA Letter of Authorization ([link removed])
* Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers Administering the Vaccine (Vaccination Providers) ([link removed])
* Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers ([link removed])
ACIP will convene on Wednesday, May 12 ([link removed]) from 11:00 a.m.–5:00 p.m. (ET) to discuss expanding its recommendations to include ages 12–15 years. Other ACIP agenda items include an update on thrombosis with thrombocytopenia syndrome, COVID-19 vaccine effectiveness studies, and an update on SARS-CoV-2 variants.
No registration is required to watch webcasts of live ACIP meetings or listen via telephone. Opportunities for public comment are described at the website.
Watch the virtual ACIP meeting ([link removed]).
Related Links
* ACIP gateway page ([link removed]) for recordings and content from previous meetings, as well as information about future meetings
* FDA’s Vaccine Development 101 ([link removed])
* FDA’s COVID-19 Vaccines ([link removed]) gateway page
* FDA’s Emergency Use Authorization for Vaccines Explained ([link removed]) web page
* FDA's Vaccine Facts: The Path for a COVID-19 Vaccine from Research to EUA ([link removed]
------------------------------------------------------------
ACIP discussed rabies vaccine and dengue vaccine on May 5; IAC summarizes meeting
The Advisory Committee on Immunization Practices (ACIP)
([link removed]) met on May 5, 2021 ([link removed]), to continue discussions on rabies vaccine and dengue vaccine. No votes were held at the meeting. Presentation slides ([link removed]) are available online.
Rabies vaccine – During its February 24–25, 2021 meeting ([link removed]), ACIP approved recommendations on use of rabies vaccine for pre-exposure prophylaxis (PrEP) in persons age 18 and older. At that time, the Committee requested additional data before making a similar recommendation for children and adolescents. During the May 5 meeting, CDC experts described multiple studies indicating no difference between primary or long-term immunogenicity in children compared to adults. The Committee also discussed the need for improved communication tools to assist healthcare providers trying to determine when rabies post-exposure prophylaxis (PEP) is appropriate. ACIP tentatively plans to vote on the use of PrEP in children and continue discussions on PEP during its June meeting.
Dengue vaccine – In the U.S., dengue fever cases occur almost entirely in Puerto Rico, although a small percentage of cases occur in other U.S. territories. Dengvaxia ([link removed]) (Sanofi Pasteur) is FDA-licensed for vaccination of persons age 9–45 years who have laboratory confirmation of a previous dengue infection. If given to persons who have not already been infected, the vaccine can act as an initial dengue infection, putting the recipient at risk for more serious disease if they are infected again. Because of the critical nature of this pre-vaccination screening, ACIP discussed test performance characteristics to include in its dengue vaccine recommendations. The Committee also discussed sample messages healthcare professionals can use in communicating with their patients. CDC staff used its Evidence to Recommendations (EtR) framework to examine the benefits and risks of the vaccine. Final votes on use of dengue vaccine are scheduled for
the June meeting.
The next regularly scheduled ACIP meeting will be held June 23–24, 2021. Information about past and future ACIP meetings ([link removed]) may be found on the ACIP website.
------------------------------------------------------------
CDC updates "FAQs for Private and Public Healthcare Providers about Implementing the CDC COVID-19 Vaccination Program in Provider Practices"
CDC has updated its web page titled FAQs for Private and Public Healthcare Providers about Implementing the CDC COVID-19 Vaccination Program in Provider Practices ([link removed]). Practices preparing to give COVID-19 vaccinations will especially benefit from this resource. A selection of the FAQs appear below.
* What are the requirements for becoming a COVID-19 vaccination provider?
* Does the program require that I provide vaccine to anyone, even if they are not currently a patient?
* What are the reporting requirements for the CDC COVID-19 Vaccination Program?
Access FAQs for Private and Public Healthcare Providers about Implementing the CDC COVID-19 Vaccination Program in Provider Practices (ht
------------------------------------------------------------
Association of Immunization Managers releases “COVID-19 Vaccine Communication Resources”
The Association of Immunization Managers (AIM) ([link removed]) released COVID-19 Vaccine Communication Resources ([link removed]), a compilation of messages and materials to support COVID-19 vaccination outreach. Materials are either publicly available or have been shared by the CDC and AIM members.
AIM enables state and jurisdiction immunization managers to work together to prevent and control vaccine-preventable diseases and improve immunization coverage.
Access COVID-19 Vaccine Communication Resources ([link removed]) for links to helpful web pages, PDF documents, and Google Drive folders.
------------------------------------------------------------
Vaccines.gov helps individuals find nearby COVID-19 vaccination sites using web and text options; available in English and Spanish
Vaccines.gov ([link removed]), powered by VaccineFinder, helps connect Americans with locations offering COVID-19 vaccines near them. This federally supported website is available in English and Spanish.
In addition to the Vaccines.gov ([link removed]) website, people in the U.S. can use a text messaging service, available in both English and Spanish. People can text their ZIP code to 438829 (GETVAX) and 822862 (VACUNA) to find three locations nearby that have COVID-19 vaccines available.
Related Link
* Healthcare IT News: Biden Administration Rolls Out COVID-19 Vaccine Text-Line ([link removed]) (5/3/21)
------------------------------------------------------------
MMWR Recap: CDC publishes COVID-19 vaccine updates on safety monitoring, anxiety-related adverse events, and effectiveness studies on May 7; previously issued as MMWR Early Releases
CDC recently published several articles about COVID-19 vaccine safety monitoring, anxiety-related adverse events, and effectiveness studies. Here is a recap:
* Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine—United States, March–April 2021 (MMWR, May 7, HTML format ([link removed]) or PDF format ([link removed])
* Anxiety-Related Adverse Event Clusters after Janssen COVID-19 Vaccination—Five U.S. Mass Vaccination Sites, April 2021 (MMWR, May 7, HTML format ([link removed]) or PDF format ([link removed])
* Effectiveness of Pfizer-BioNTech and Moderna Vaccines against COVID-19 among Hospitalized Adults Aged ≥65 Years—United States, January–March 2021 (MMWR, May 7, HTML format ([link removed]) or PDF format ([link removed])
Related Link
* MMWR ([link removed]) gateway page provides access to MMWR Weekly, MMWR Recommendations and Reports, MMWR Surveillance Summaries, and MMWR Supplements
------------------------------------------------------------
Sabin-Aspen Vaccine Science and Policy Group releases its newest meeting report, “Powering Vaccine R&D: Opportunities for Transformation”
The Sabin-Aspen Vaccine Science & Policy Group ([link removed]) has published its third meeting report titled Powering Vaccine R&D: Opportunities for Transformation ([link removed]). The Sabin-Aspen Vaccine Science & Policy Group brings together senior leaders across many disciplines to examine some of the most challenging vaccine-related issues and drive impactful change. IAC's Dr. Kelly Moore is a charter member of this group.
The group developed a package of five big ideas to engender a more efficient and responsive approach to vaccine R&D.
* Define leadership roles, responsibilities, and mechanisms of accountability to prepare for the R&D demands that surface in a pandemic
* Propel a transdisciplinary research effort built around partnerships to expand and advance vaccine science
* Reimagine clinical trials
* Restructure regulatory science to reflect advances in vaccine R&D
* Position vaccines as a public good and align incentives so that benefits accrue to all sectors of society
Two prior reports, Accelerating the Development of a Universal Influenza Vaccine ([link removed]) and Meeting the Challenges of Vaccination Hesitancy ([link removed]) are available on the Sabin-Aspen Vaccine Science & Policy Group ([link removed]) web page.
Access Powering Vaccine R&D: Opportunities for Transformation in HTML format ([link removed]) or in PDF format (downloadable from the report web page).
------------------------------------------------------------
CDC publishes “Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021” in MMWR, describing use of botulinum antitoxin
CDC has published Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021 ([link removed]) in the May 7 issue of MMWR Recommendations and Reports, describing use of botulinum antitoxin. The summary appears below.
Botulism is a rare, neurotoxin-mediated, life-threatening disease characterized by flaccid descending paralysis that begins with cranial nerve palsies and might progress to extremity weakness and respiratory failure. Botulinum neurotoxin, which inhibits acetylcholine release at the neuromuscular junction, is produced by the anaerobic, gram-positive bacterium Clostridium botulinum and, rarely, by related species (C. baratii and C. butyricum). Exposure to the neurotoxin occurs through ingestion of toxin (foodborne botulism), bacterial colonization of a wound (wound botulism) or the intestines (infant botulism and adult intestinal colonization botulism), and high-concentration cosmetic or therapeutic injections of toxin (iatrogenic botulism). In addition, concerns have been raised about the possibility of a bioterrorism event involving toxin exposure through intentional contamination of food or drink or through aerosolization. Neurologic symptoms are similar regardless of exposure route. Treatment involves supportive care, intubation and mechanical ventilation when necessary, and administration of botulinum antitoxin.…
...If botulism is suspected, immediately contact the local or state health department’s emergency on-call staff to arrange an emergency expert clinical consultation and, when indicated, request botulinum antitoxin from CDC....
...The only specific therapy for botulism is botulinum antitoxin.…
Access the MMWR article in HTML format ([link removed]) or in PDF format ([link removed]) .
Related Link
* MMWR ([link removed]) gateway page provides access to MMWR Weekly, MMWR Recommendations and Reports, MMWR Surveillance Summaries, and MMWR Supplements
------------------------------------------------------------
CDC’s Dr. Anne Schuchat named 2021 Service to America Medal Finalist; you can vote daily for your favorite finalist
It’s time to vote again! CDC's Principal Deputy Director Anne Schuchat, MD (RADM, USPHS, RET), has been named a finalist in the Partnership for Public Service’s 2021 Service to America Medals ([link removed]), known as the “Sammies.” Dr. Schuchat is a finalist in the Paul A. Volcker Career Achievement Category ([link removed]) that recognizes a federal employee for leading significant and sustained accomplishments throughout a federal career of 20 or more years. A description of the "Sammies" appears below.
The Sammies were named for Samuel J. Heyman, founder of the Partnership for Public Service. This year there are 29 finalists for the Sammies, and members of the public can vote online to select the federal employee they believe has made the most significant contributions in public service on the People’s Choice ([link removed]) webpage. The winners will be announced in late September.
Other noteworthy immunization champion nominees include FDA's Peter Marks, MD, PhD ([link removed]), and NIH's Kizzmekia Corbett, PhD, and Barney Graham, MD, PhD ([link removed]).
The public gets a say, so vote for the federal employee ([link removed]) whose service to America impresses you most. You can vote once per day from any email address.
Related Link
* Press Release: CDC Principal Deputy Director Named 2021 Service to America Medal Finalist ([link removed]) (5/3/21)
------------------------------------------------------------
Celebrate vaccination progress with patients and staff! Order IAC’s “I Got My COVID-19 Vaccine” buttons—stickers available, too.
IAC now offers “I Got My COVID-19 Vaccine ([link removed])” buttons and stickers for purchase. Give them as gifts to family, friends, and colleagues. Place them on clothing, lab coats, uniforms, jackets, lanyards, ID badges, or backpacks to demonstrate confidence in COVID-19 vaccination.
Buttons: Wear them to reassure your patients and remind those around you to protect themselves from COVID-19. These are not just for people in healthcare! Give them to vaccinated people in your social network who are working to keep COVID-19 from spreading, such as your parents, hair stylist, grocer, teacher, and religious leader.
* Description: Bright yellow, black and blue text, metal pin that clasps on the back
* Packaging: Bag of 25 buttons
* Dimension: 1.5" across
* To order: See Shop IAC: COVID-19 Vaccine Buttons and Stickers ([link removed]) for quantity and pricing options
Stickers: Give away to COVID-19 vaccine recipients or vaccinated clinic staff!
* Description: Bright yellow stickers on a roll with an easy-peel-off back and perforations between stickers to make them easy to tear off and share
* Packaging: Roll of 200 stickers
* Dimension: 1.5" across
* To order: See Shop IAC: COVID-19 Vaccine Buttons and Stickers ([link removed]) for quantity and pricing options
Please note: Through a separate program supported by CDC, public health departments and selected CDC nonprofit Vaccinate with Confidence ([link removed]) campaign partners have been notified about how to receive limited supplies of these items at no cost.
For questions, call 651-647-9009 or email
[email protected].
Related Links
* Shop IAC: COVID-19 Vaccine Buttons and Stickers ([link removed])
* Shop IAC ([link removed]) gateway page: All the buttons, stickers, laminated schedules, record cards, and other products offered by IAC
------------------------------------------------------------
READY TO SHIP! ORDER IAC’S LAMINATED VERSION OF CDC’S 2021 IMMUNIZATION SCHEDULE TODAY!
IAC's laminated version of the 2021 U.S. child/adolescent immunization schedule ([link removed]) is available for order. The 2021 U.S. adult immunization schedule ([link removed]) has sold out.
These schedules are ideal for use in any busy healthcare setting where vaccinations are given. Their tough coating can be wiped down, and they’re durable enough to stand up to a year's worth of use.
The child/adolescent schedule is eight pages (i.e., four double-sided pages), but folds down to a convenient 8.5" x 11" size.
With color coding for easy reading, our laminated schedules replicate the original CDC formatting, including the essential tables and notes.
PRICING
1–4 copies: $7.50 each
5–19 copies: $5.50 each
20–99 copies: $4.50 each
100–499 copies: $4.00 each
500–999 copies: $3.50 each
For quotes on customizing or placing orders of 1,000 copies or more, call 651-647-9009 or email
[email protected].
Visit the Shop IAC: Laminated Schedules ([link removed]) web page for more information on the schedules, to view images of all the pages, and to download the order form today!
Related Links
* IAC’s laminated Child/Adolescent Immunization Schedules (0–18 years) ([link removed]) web page
* IAC’s Shop IAC ([link removed]) section on immunize.org
* CDC’s Immunization Schedules for 2021 ([link removed])
------------------------------------------------------------
IAC Spotlight! Our IAC Image Library leads you to hundreds of disease photos to educate staff and patients about the importance of vaccination
The IAC Image Library ([link removed]) gateway page offers hundreds of photos to educate staff and patients about the importance of vaccination. The gallery of digital images includes photos of people affected by vaccine-preventable diseases; micrographs of viruses, bacteria, and pathology specimens; and pictures of healthcare professionals vaccinating children, teens, and adults. All of the images are free to download. Please follow any copyright requirements noted.
To easily locate this gateway page, use the “Guide to Immunize.org” at the bottom of every immunize.org web page.
Related Link
* IAC's Image Library ([link removed]) gateway page
------------------------------------------------------------
IAC EXPERTS CALLED ON BY NEWS MEDIA
With vaccines in the news so much lately, journalists have sought out IAC experts to communicate the intricacies of running a quality vaccination program. Our insights have helped explain vaccines to the public and policy makers. We want to help them understand the complex work vaccinators do. We've reached mass markets and local stations, across the U.S. and overseas, via print, radio, television, blogs, and more. Here is a selection of our recent citations:
* NBC: Pfizer, BioNTech Ask FDA for Full Approval of COVID-19 Vaccine ([link removed]) (5/7/21)
* NPR Morning Edition: U.S. Backs Waiving International Patent Protections for COVID Vaccines ([link removed]) (5/6/21)
* The Atlantic: The Era of Mass Vaccinations Is Ending ([link removed]) (5/4/21)
* NBC: FDA Wants ‘Significant’ Amount of Extra Data on AstraZeneca’s COVID Vaccine ([link removed]) (4/30/21)
Related Link
* IAC in the News ([link removed]) gateway page
------------------------------------------------------------
Not-to-miss immunization articles in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* Becker's Hospital Review: What Full Approval of Pfizer COVID-19 Vaccine Could Mean for Rollout ([link removed]) (5/5/21)
* White House: President Biden to Announce Goal to Administer at Least One Vaccine Shot to 70% of the U.S. Adult Population by July 4th ([link removed]) (5/4/21)
* New York Times: With COVID Vaccines for Teens and Kids, Timing Matters ([link removed] ) (5/4/21)
* University Business: State-by-State Look at Colleges Requiring COVID-19 Vaccines ([link removed]) (5/3/21)
* Washington Post: How to Sell the Coronavirus Vaccines to a Divided, Uneasy America ([link removed]) (4/26/21)
------------------------------------------------------------
World News
------------------------------------------------------------
CDC and WHO report on progress toward worldwide polio eradication in MMWR and Weekly Epidemiological Record, respectively
CDC published Surveillance to Track Progress toward Polio Eradication—Worldwide, 2019–2020 ([link removed]) in the May 7 issue of MMWR ([link removed]). On the same day, WHO's Weekly Epidemiological Record published an article with a similar title ([link removed]). A media summary of the MMWR article appears below.
Key poliovirus surveillance indicators for 2020 fell substantially compared to 2019 in many of the 42 priority countries due to the COVID-19 pandemic. These findings emphasize the need for the rigorous search for cases of new-onset, floppy weakness or paralysis among children (high-quality surveillance) to be restored in 2021 while maintaining pandemic response and infection control protocols. The pathway to polio eradication requires promptly detecting spread of poliovirus, primarily through acute flaccid paralysis (AFP) surveillance. In 2020, the COVID-19 pandemic substantially impacted polio eradication activities in many of the 42 priority countries deemed to be at high risk for poliovirus transmission. In most countries, field surveillance activities were curtailed and polio staff and assets were repurposed to support pandemic response efforts. While 90% of priority countries in the World Health Organization Eastern Mediterranean Region met AFP surveillance performance indicators nationally in 2020, only 48% of the priority countries in the African Region and 40% in other regions did so. Standard surveillance activities must be restored while maintaining necessary infection control precautions.
Related Links
* MMWR ([link removed]) gateway page provides access to MMWR Weekly, MMWR Recommendations and Reports, MMWR Surveillance Summaries, and MMWR Supplements
* Current issue and archives of the Weekly Epidemiological Record ([link removed])
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
IN IAC’S “VIDEO OF THE WEEK,” CDC USES AMERICAN SIGN LANGUAGE TO SHARE WHAT TO EXPECT WHEN SOMEONE GETS VACCINATED AGAINST COVID-19
In this CDC video, American Sign Language (ASL) COVID-19 Vaccine—What to Expect ([link removed]), a sign language interpreter shares what to expect when someone gets vaccinated against COVID-19. The video discusses vaccine safety, types of vaccines, getting the vaccine, and what to expect after receiving the vaccine. If you do not understand ASL, click the "CC" icon on the bottom right of the video screen for Closed Captioning.
Visit the whole collection at the VOTW archive ([link removed]).
------------------------------------------------------------
CHOP’s VEC expands its My COVID-19 Vaccine Experience video series to include racially and ethnically diverse colleagues, and young adults
Children's Hospital of Philadelphia's (CHOP) Vaccine Education Center has expanded its My COVID-19 Vaccine Experience ([link removed]) video series to include African American, Latinx, and young adult colleagues from CHOP talking about why they decided to get vaccinated or their experiences once they were vaccinated. The collection now includes 18 videos, eight of them in Spanish.
Share these videos with your friends, colleagues, and across social media!
Related Link
* VEC's My COVID-19 Vaccine Experience ([link removed]) web page
------------------------------------------------------------
NOW AVAILABLE IN SPANISH! IAC’S “I GOT MY COVID-19 VACCINE” FACEBOOK PROFILE PHOTO FRAME
Share your excitement about COVID-19 vaccination and inspire your friends! When you have received your COVID-19 vaccine, add IAC's new "I Got My COVID-19 Vaccine" Facebook photo frame to liven up your profile picture!
The photo frame (or marco de la foto) is now available in both English and Spanish.
You can obtain the frame in two ways:
* Click your profile picture, select “update picture,” and then select “add a frame.” Search for #igotmycovid19vaccine and select it.
* Accept the frame in English by clicking this link: www.facebook.com/profilepicframes/? selected_overlay_id=2361854253958052 ([link removed])
* Accept the frame in Spanish by clicking this link: www.facebook.com/profilepicframes/?selected_overlay_id=517990259207530
Together we can end the COVID-19 pandemic!
------------------------------------------------------------
USE IAC'S EXPANDED "REPOSITORY OF RESOURCES FOR MAINTAINING IMMUNIZATION DURING THE COVID-19 PANDEMIC" FOR CATCH-UP INITIATIVES
IAC now offers nearly 300 items in its Repository of Resources for Maintaining Immunization during the COVID-19 Pandemic ([link removed]) gateway page to assist in maintaining routine immunization rates during the COVID-19 pandemic. Located on the website of the National Network of Immunization Coalitions ([link removed]), a project of IAC, this repository includes links to both national and state-level policies and guidance; advocacy materials, including talking points, webinars, press releases, articles, and social media posts; and telehealth resources.
If you have a resource to suggest for the repository, please send a message to
[email protected].
Related Link
* National Network of Immunization Coalitions ([link removed]) website
------------------------------------------------------------
Education and Training
------------------------------------------------------------
NATIONAL ACADEMY OF MEDICINE WILL OFFER "INTERNATIONAL WORKSHOP ON COVID-19 LESSONS TO INFORM PANDEMIC INFLUENZA RESPONSE" ON MAY 18, 21, AND 25
The National Academies of Sciences, Engineering, and Medicine ([link removed]) will present a three-part workshop series titled International Workshop on COVID-19 Lessons to Inform Pandemic Influenza Response ([link removed]) in May. Workshop dates, times, and topics appear below.
* Global Coordination ([link removed]) on Tuesday, May 18 from 7:00–10:30 a.m. (ET)
* Supply Chain Cascade ([link removed]) on Friday, May 21 from 8:00–11:30 a.m. (ET)
* Lessons Learned Across Fields ([link removed]) on Tuesday, May 25 from 8:00–11:30 a.m. (ET)
This global public workshop will convene international experts, thought leaders, and other stakeholders to discuss the emerging evidence on these unprecedented actions related to COVID-19 that could inform and advance pandemic and seasonal influenza vaccine preparedness efforts and subsequent response.
Register for the workshop series ([link removed]).
------------------------------------------------------------
Immunization PSAs from the Archive
------------------------------------------------------------
IN THIS JAUNTY PSA FROM 2001 BY THE PHOENIX FIRE DEPARTMENT, DIAMONDBACK LEFT FIELDER LUIS GONZALEZ HITS A HOME RUN PROMOTING CHILDHOOD VACCINATIONS, SHARING WHY HE AND HIS WIFE VACCINATED THEIR TRIPLETS
In this 2001 jaunty public service announcement (PSA) from the Phoenix Fire Department ([link removed]), Diamondback left fielder Luis Gonzalez promotes childhood vaccinations and shares why he and his wife vaccinated their triplets. This PSA is part of a collection curated by vaccine expert William L. Atkinson, MD, MPH.
Previous PSAs featured in “From the Archives” are available when viewing this Vimeo video ([link removed]).
[link removed]
IAC Express
IAC Express Home ([link removed])
2021 Issues ([link removed])
2020 Issues ([link removed])
2019 Issues ([link removed])
2018 Issues ([link removed])
2017 ([link removed]) – 1997 Issues ([link removed])
[link removed]
[link removed]
[link removed]
[link removed]
------------------------------------------------------------
Video of the Week
[link removed]
American Sign Language (ASL) COVID-19 Vaccine—What to Expect: This CDC video in ASL shares what to expect when someone gets vaccinated against COVID-19. The video discusses vaccine safety, types of vaccines, getting the vaccine, and what to expect after receiving the vaccine. If you do not understand ASL, click the "CC" icon on the bottom right of the video screen for captions. [4:45]
Visit the VOTW archive ([link removed])
------------------------------------------------------------
[link removed]
[link removed]
------------------------------------------------------------
Follow Us
[link removed]
[link removed]
[link removed]
------------------------------------------------------------
Technically Speaking
[link removed]
Read Dr. Wexler's column for the Vaccine Education Center's monthly newsletter, Vaccine Update
------------------------------------------------------------
Vaccinating Adults: A Step-by-Step Guide
[link removed]
New! IAC's 142-page book available for free download ([link removed]).
------------------------------------------------------------
Calendar of Events
[link removed]
Conferences, meetings, and training opportunities
------------------------------------------------------------
Patient Record Cards
[link removed]
Record cards for patients --child & teen ([link removed]), adult ([link removed]), and lifetime ([link removed]) -- are printed on durable paper and sized to fit in a wallet when folded
------------------------------------------------------------
DVD: Immunization Techniques
[link removed]
Every practice should have this award winning, "how-to" training video
------------------------------------------------------------
Protect Newborns Guidebook
[link removed]
Comprehensive guide Hepatitis B: What Hospitals Need to Do to Protect Newborns ([link removed])
------------------------------------------------------------
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH (
[email protected])
Managing Editor
John Grabenstein, RPh, PhD (
[email protected])
Associate Editor
Sharon Humiston, MD, MPH (
[email protected])
Writer/Publication Coordinator
Taryn Chapman, MS (
[email protected])
Courtnay Londo, MA (
[email protected])
Style and Copy Editor
Marian Deegan, JD (
[email protected])
Web Edition Manager
Sheila M. Franey, MA
Contributing Writer
Laurel H. Wood, MPA (
[email protected])
Technical Reviewer
Robin VanOss (
[email protected])
About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue ([link removed]).
IAC Express is supported in part by Grant No. 6NH23IP922550 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC.
IAC Express Disclaimer ([link removed])
ISSN: 1526-1786
Our mailing address:
2550 University Avenue West, Suite 415 North
Saint Paul, MN 55114
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe
[email protected] from this list:
[link removed]